In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a CP 15,467 61 Drug Master File in Korea (CP 15,467 61 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of CP 15,467 61. The MFDS reviews the CP 15,467 61 KDMF as part of the drug registration process and uses the information provided in the CP 15,467 61 KDMF to evaluate the safety and efficacy of the drug.
After submitting a CP 15,467 61 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their CP 15,467 61 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of CP 15,467 61 suppliers with KDMF on PharmaCompass.